Joint letter

Promoting transparent and needs-driven EU R&D policies, Research and Development

Joint letter requesting the publication of the proposed revision of the EU pharmaceutical legislation

Dear Commissioner Kyriakides, We, the signatory organisations representing civil society, patients, consumers, and healthcare professionals, join other stakeholders in calling the European Commission to publish…

actionsantemondiale9 March 2023

Recommendations

Promoting transparent and needs-driven EU R&D policies, Research and Development

GHA’s recommendations to ensure future EU research programmes really deliver for people

The European Commission recently held the largest public consultation ever on the past, present, and future of the its research programmes: Horizon 2020 and Horizon Europe In…

actionsantemondiale2 March 2023

Hiring ! GHA is looking for a consultant

  JOINS US ! GHA is looking for a consultant to research the role of multilateral development banks (MDBs) before and during the Covid-19 pandemic,…

actionsantemondiale7 February 2023

Event

ACCESS DENIED: What happens when Big Pharma is in the driver’s seat, Promoting transparent and needs-driven EU R&D policies

Report Launch Event – Access Denied: What happens when Big Pharma is in the driver’s seat

Global Health Advocates and STOPAIDS launched a new report series “Access Denied – What happens when Big Pharma is in the driver’s seat”. Check it…

actionsantemondiale19 January 2023

Report

ACCESS DENIED: What happens when Big Pharma is in the driver’s seat

Access Denied – What happens when Big Pharma is in the driver’s seat

  Global Health Advocates, together with STOPAIDS, commissioned a report series, exploring how a lack of transparency in the pharmaceutical industry and the European Union…

actionsantemondiale18 January 2023

Global Health Advocates reveals its 2022-2027 strategy!

After a year-long process, we’re pleased to publish our new 5-year strategy. On the road to 2030, we will focus on addressing two major challenges:…

actionsantemondiale17 January 2023

Our 2023 best wishes for global health

What should happen in 2023 to make progress in the fight against health inequalities?  Our proposed good resolutions:Ensure the right to health everywhereNo more compromising…

actionsantemondiale1 January 2023

Reactive

Cooperation for development EU, Funding and quality of aid

Global Health Advocates’ Statement on the Communication on the EU Global Health Strategy

Today, the European Commission publishes its new EU Global Health Strategy (GHS), which replaces the Commission’s first and previous communication from 2010. Since its announcement,…

actionsantemondiale30 November 2022

Recommendations

Promoting transparent and needs-driven EU R&D policies

Joint Statement on the Revision of the Pharmaceutical Legislation

Joint Statement on the Revision of the Pharmaceutical Legislation by associations representing healthcare providers, patients, healthcare professionals and payers  Enhancing patients’ access to high-quality and affordable…

actionsantemondiale9 November 2022

Recommendations

Cooperation for development EU

An essential check-list for the new EU Global Health Strategy: 16 points that will make it or break it

The feedback for the European Commission’s public consultation about the renewal of its global health strategy (GHS) is now closed. We have been following this…

actionsantemondiale7 November 2022

Joint declaration

Promoting transparent and needs-driven EU R&D policies

Together for Access to Medicines

The members of the European Alliance for Responsible R&D and Affordable Medicines have joint their voices in the Joint Rome Declaration to raise awareness and…

actionsantemondiale20 October 2022

Recommendations

Fight against pandemics

GHA’s recommendation ahead of the FIF Board Meeting

The Covid-19 pandemic has highlighted the urgent need for collective actions and additional investment in pandemic prevention, preparedness, and response. To address the gaps, under…

actionsantemondiale7 October 2022

Blog series

Promoting transparent and needs-driven EU R&D policies

We believe in alternative funding and pricing models that can encourage pharmaceutical companies to innovate and to charge reasonable prices

By Ella Weggen, Global health advocate at Wemos

actionsantemondiale28 September 2022

Blog series

Promoting transparent and needs-driven EU R&D policies

It is clear that transparency creates trust, and that the Political institutions should be irreproachable in that regard

By Tilly Metz, Member of the EU Parliament

actionsantemondiale28 September 2022

Blog series

Transparency is key to unlocking better policies

By Ellen T'Hoen, lawyer and director of Medicine Law & Policy

actionsantemondiale28 September 2022

Press release

Fight against pandemics, HIV/AIDS, TB & Malaria, Whatever It Takes

The EU confirms its leadership in the fight against pandemics

The Global Fund to Fight HIV/AIDS, Tuberculosis and Malaria held its 7th Replenishment Conference today in New York. In 20 years, its investments have saved…

actionsantemondiale21 September 2022

Reactive

Cooperation for development EU, Promoting transparent and needs-driven EU R&D policies

SOTEU 2022: blackout on health

Today, Ursula von der Leyen delivered her State of the European Union speech. The President of the Commission reiterated the EU’s unwavering support to Ukraine…

actionsantemondiale14 September 2022

Fight against pandemics, HIV/AIDS, TB & Malaria

The Global Fund has saved 50 million lives since its creation!

The 2021 results report of the Global Fund to Fight HIV/AIDS, Tuberculosis, and Malaria has just been published: since its creation in 2002, the Fund…

actionsantemondiale13 September 2022